Excessive drooling is a sign of greater dysfunction in patients with Parkinson’s diseaseJune 25, 2021Parkinson's DiseaseMovement Disorders
Cortical surface changes tied to risk for movement disorders in schizophreniaJune 21, 2021Movement Disorders
Neurodegeneration complicates psychiatric care for Parkinson’s patientsJune 21, 2021Movement DisordersParkinson's Disease
FDA clears next-generation DBS system for movement disordersJune 8, 2021Movement DisordersParkinson's Disease
Deep brain stimulation is effective over the long haulJune 4, 2021Parkinson's DiseaseMovement Disorders
Young adults with epilepsy face higher mental illness risksMay 24, 2021Movement DisordersEpilepsy & Seizures
Psychosis, depression tied to neurodegeneration in Parkinson’sMay 24, 2021Movement DisordersParkinson's Disease
Long-term benefit for DBS in treating Parkinson’s disease motor symptomsApril 26, 2021Parkinson's DiseaseMovement Disorders
Watch for abnormal movements in hospitalized COVID-19 patientsApril 19, 2021Movement DisordersCOVID-19 Updates
Can exercise prevent cognitive decline in patients with early Parkinson’s disease?April 8, 2021Parkinson's DiseaseMovement Disorders
Type 2 diabetes linked to increased risk for Parkinson’sMarch 17, 2021Movement DisordersParkinson's Disease
Neurologic disorders ubiquitous and rising in the U.S.March 2, 2021Alzheimer's & CognitionEpilepsy & SeizuresHeadache & MigraineMovement DisordersMultiple SclerosisNeuromuscular DisordersParkinson's Disease
Ultrasound ablation for Parkinson’s disease: Benefit limited by adverse effectsJanuary 7, 2021Parkinson's DiseaseMovement Disorders
Sublingual apomorphine alleviates off episodes in Parkinson’s diseaseNovember 3, 2020Parkinson's DiseaseMovement Disorders
